Clinical trial
Desmopressin Response in the Young
NCT00230594 · Ferring Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00230594 |
|---|---|
| Title | Desmopressin Response in the Young |
| Official title | Desmopressin Response in the Young: A Double-blind, Randomised, Placebo-controlled, Dose-titration Study With Three Different Doses (120 Mcg, 240 Mcg and 360 Mcg) of Desmopressin Administered as a New Melt Tablet in Children and Adolescents With Primary Nocturnal Enuresis (PNE). |
| Acronym | DRY |
| Lead sponsor | Ferring Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Primary Nocturnal Enuresis |
| Intervention type | Drug |
| Interventions | desmopressin, placebo |
| Enrollment | 132 |
| Start date | Jul 1, 2004 |
| Primary completion | Jan 1, 2006 |
| Completion | Feb 1, 2006 |
| First posted | Oct 3, 2005 |
| Last update posted | May 19, 2011 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: